Antidepressants: Influence on cancer and immunity?

dc.creatorFrick, Luciana Romina
dc.creatorRapanelli, Maximiliano
dc.date.accessioned2015-10-09T16:04:56Z
dc.date.accessioned2018-11-06T13:00:46Z
dc.date.available2015-10-09T16:04:56Z
dc.date.available2018-11-06T13:00:46Z
dc.date.created2015-10-09T16:04:56Z
dc.date.issued2013-01-28
dc.identifierFrick, Luciana Romina; Rapanelli, Maximiliano; Antidepressants: Influence on cancer and immunity?; Elsevier; Life Sciences; 92; 10; 28-1-2013; 525-532
dc.identifier0024-3205
dc.identifierhttp://hdl.handle.net/11336/2465
dc.identifier1879-0631
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1872165
dc.description.abstractTwo decades ago, it was hypothesized that antidepressants could alter the course of neoplastic diseases. However, contradictory findings indicated that antidepressants could either have carcinogenic properties or improve the disease outcome. Intriguingly, controversial results were reported on the action of antidepressant drugs on immune function. Further hypotheses proposed that antidepressants could indirectly affect the cancer prognosis through the modulation of antitumor activity. Here we review the literature in order to elucidate the influence of antidepressants on cancer and immunity.
dc.languageeng
dc.publisherElsevier
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.lfs.2013.01.020
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0024320513000489
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectSTRESS
dc.subjectIMMUNITY
dc.subjectDEPRESSION
dc.titleAntidepressants: Influence on cancer and immunity?
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución